Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Livzon Pharmaceutical Group ( (HK:1513) ) has issued an announcement.
Livzon Pharmaceutical Group Inc. has announced the composition of its board of directors and the membership of its board committees. This announcement provides clarity on the leadership structure of the company, which could influence its strategic direction and governance practices, potentially impacting stakeholders and the company’s market positioning.
The most recent analyst rating on (HK:1513) stock is a Sell with a HK$24.00 price target. To see the full list of analyst forecasts on Livzon Pharmaceutical Group stock, see the HK:1513 Stock Forecast page.
More about Livzon Pharmaceutical Group
Livzon Pharmaceutical Group Inc. operates in the pharmaceutical industry, focusing on the development, production, and distribution of pharmaceutical products. The company is known for its comprehensive range of healthcare solutions, catering to various market needs.
Average Trading Volume: 1,090,004
Technical Sentiment Signal: Buy
Current Market Cap: HK$31.19B
For an in-depth examination of 1513 stock, go to TipRanks’ Stock Analysis page.